141 related articles for article (PubMed ID: 28495087)
1. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
Vale N; Ferreira A; Fernandes I; Alves C; Araújo MJ; Mateus N; Gomes P
Bioorg Med Chem Lett; 2017 Jul; 27(13):2898-2901. PubMed ID: 28495087
[TBL] [Abstract][Full Text] [Related]
2. Combination of Gemcitabine with Cell-Penetrating Peptides: A Pharmacokinetic Approach Using In Silico Tools.
Ferreira A; Lapa R; Vale N
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31690028
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I
ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402
[TBL] [Abstract][Full Text] [Related]
4. Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan.
Ma L; Chen Y; Wang X; Xiong M; Sun Y; Zhang X; Zhao Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2920-2924. PubMed ID: 30017318
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
[TBL] [Abstract][Full Text] [Related]
6. Thiophene-expanded guanosine analogues of Gemcitabine.
Chen Z; Ku TC; Seley-Radtke KL
Bioorg Med Chem Lett; 2015 Oct; 25(19):4274-6. PubMed ID: 26316465
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker.
Trznadel R; Singh A; Kleczewska N; Liberska J; Ruszkowski P; Celewicz L
Bioorg Med Chem Lett; 2019 Sep; 29(18):2587-2594. PubMed ID: 31400940
[TBL] [Abstract][Full Text] [Related]
8. Cell-Penetrating Peptide-Conjugated BF
Laxman K; Reddy BPK; Robinson A; Srivastava R; Ravikanth M
ChemMedChem; 2020 Oct; 15(19):1783-1787. PubMed ID: 32726512
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and in vitro cytotoxicity studies of inclusion complex between gemcitabine and cucurbit[7]uril host.
Buczkowski A; Gorzkiewicz M; Stepniak A; Malinowska-Michalak M; Tokarz P; Urbaniak P; Ionov M; Klajnert-Maculewicz B; Palecz B
Bioorg Chem; 2020 Jun; 99():103843. PubMed ID: 32305692
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Bergman AM; Adema AD; Balzarini J; Bruheim S; Fichtner I; Noordhuis P; Fodstad O; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Invest New Drugs; 2011 Jun; 29(3):456-66. PubMed ID: 20066470
[TBL] [Abstract][Full Text] [Related]
11. Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation.
Cox N; Kintzing JR; Smith M; Grant GA; Cochran JR
Angew Chem Int Ed Engl; 2016 Aug; 55(34):9894-7. PubMed ID: 27304709
[TBL] [Abstract][Full Text] [Related]
12. Ridaifen-F conjugated with cell-penetrating peptides inhibits intracellular proteasome activities and induces drug-resistant cell death.
Tanaka M; Zhu Y; Shionyu M; Ota N; Shibata N; Watanabe C; Mizusawa A; Sasaki R; Mizukami T; Shiina I; Hasegawa M
Eur J Med Chem; 2018 Feb; 146():636-650. PubMed ID: 29407987
[TBL] [Abstract][Full Text] [Related]
13. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M
Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity.
Mohammadi S; Zakeri-Milani P; Golkar N; Farkhani SM; Shirani A; Shahbazi Mojarrad J; Nokhodchi A; Valizadeh H
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1572-1585. PubMed ID: 28933182
[TBL] [Abstract][Full Text] [Related]
15. Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
Geromichalou E; Sayyad N; Kyriakou E; Chatzikonstantinou AV; Giannopoulou E; Vrbjar N; Kalofonos HP; Stamatis H; Tzakos AG
Eur J Med Chem; 2015; 96():47-57. PubMed ID: 25874330
[TBL] [Abstract][Full Text] [Related]
16. Combination of DN604 with gemcitabine led to cell apoptosis and cell motility inhibition via p38 MAPK signaling pathway in NSCLC.
Wang X; Chen F; Gou S
Bioorg Chem; 2020 Nov; 104():104234. PubMed ID: 32920359
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy.
Hawryłkiewicz A; Ptaszyńska N
Molecules; 2021 Jan; 26(2):. PubMed ID: 33445797
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity.
Abu-Fayyad A; Nazzal S
Int J Pharm; 2017 Aug; 528(1-2):463-470. PubMed ID: 28627455
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
[TBL] [Abstract][Full Text] [Related]
20. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
